This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boros, D. L.
Right arrow Articles by Whitfield, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boros, D. L.
Right arrow Articles by Whitfield, J. R.

 Previous Article  |  Next Article 

Infection and Immunity, March 1999, p. 1187-1193, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Enhanced Th1 and Dampened Th2 Responses Synergize To Inhibit Acute Granulomatous and Fibrotic Responses in Murine Schistosomiasis Mansoni

Dov L. Boros,* and Joel R. Whitfield

Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201

Received 10 July 1998/Returned for modification 8 September 1998/Accepted 3 December 1998

In murine schistosomiasis mansoni, CD4+ Th1 and Th2 cells participate in the ovum-induced granulomatous inflammation. Previous studies showed that the interleukin-12 (IL-12)-induced Th1 response strongly suppressed the Th2-cell-mediated pulmonary granuloma development in naive or primed mice. However, liver granulomas were only moderately suppressed in egg-vaccinated, recombinant IL-12 (rIL-12)-treated infected mice. The present study shows that repeated rIL-12 injections given during early granuloma development at 5 to 7 weeks after infection prolonged the Th1 phase and resulted in gamma interferon-mediated suppression of liver granulomas. The timing is crucial: if given at 6 to 8 weeks, during the Th2-dominated phase of florid granuloma growth, the treatment is ineffective. Daily injections of rIL-12 given between 5 and 7.5 weeks during the period of granuloma growth achieved a somewhat-stronger diminution in granuloma growth with less deposition of collagen but caused 60% mortality and liver pathology. In contrast, combined treatment with rIL-12 and anti-IL-4-anti-IL-10 monoclonal antibody (MAb) injections given during the Th2 phase strongly inhibited liver granuloma growth without mortality. The diminished inflammatory response was accompanied by less deposition of collagen in the liver. Moreover, neutralization of endogenous IL-12 by anti-IL-12 MAbs effectively decreased the early Th1 phase (between 5 and 6 weeks after infection) but not the developing Th2 phase (5 to 7 weeks) of granuloma development. These studies indicate that the granulomatous response in infected mice can be manipulated by utilizing the Th1-Th2-subset antagonism with potential salutary results in the amelioration of fibrous pathology.

* Corresponding author. Mailing address: Department of Immunology and Microbiology, Wayne State University School of Medicine, 540 E. Canfield Ave., Detroit, MI 48201. Phone: (313) 577-1493. Fax: (313) 577-1155. E-mail: dboros{at}med.wayne.edu.

Infection and Immunity, March 1999, p. 1187-1193, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Butrous, G., Ghofrani, H. A., Grimminger, F. (2008). Pulmonary Vascular Disease in the Developing World. Circulation 118: 1758-1766 [Full Text]  
  • Isoda, K., Sawada, S., Ayaori, M., Matsuki, T., Horai, R., Kagata, Y., Miyazaki, K., Kusuhara, M., Okazaki, M., Matsubara, O., Iwakura, Y., Ohsuzu, F. (2005). Deficiency of Interleukin-1 Receptor Antagonist Deteriorates Fatty Liver and Cholesterol Metabolism in Hypercholesterolemic Mice. J. Biol. Chem. 280: 7002-7009 [Abstract] [Full Text]  
  • Stavitsky, A. B. (2004). Regulation of Granulomatous Inflammation in Experimental Models of Schistosomiasis. Infect. Immun. 72: 1-12 [Full Text]  
  • Jakubzick, C., Kunkel, S. L., Joshi, B. H., Puri, R. K., Hogaboam, C. M. (2002). Interleukin-13 Fusion Cytotoxin Arrests Schistosoma mansoni Egg-Induced Pulmonary Granuloma Formation in Mice. Am. J. Pathol. 161: 1283-1297 [Abstract] [Full Text]  
  • Lundy, S. K., Boros, D. L. (2002). Fas Ligand-Expressing B-1a Lymphocytes Mediate CD4+-T-Cell Apoptosis during Schistosomal Infection: Induction by Interleukin 4 (IL-4) and IL-10. Infect. Immun. 70: 812-819 [Abstract] [Full Text]  
  • Ebrahimi, B., Dutia, B. M., Brownstein, D. G., Nash, A. A. (2001). Murine Gammaherpesvirus-68 Infection Causes Multi-Organ Fibrosis and Alters Leukocyte Trafficking in Interferon-{{gamma}} Receptor Knockout Mice. Am. J. Pathol. 158: 2117-2125 [Abstract] [Full Text]  
  • Chen, Y., Boros, D. L. (1999). Polarization of the Immune Response to the Single Immunodominant Epitope of p38, a Major Schistosoma mansoni Egg Antigen, Generates Th1- or Th2-Type Cytokines and Granulomas. Infect. Immun. 67: 4570-4577 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»